Plaque Psoriasis Treatment Market By Product Type (Interleukin Inhibitors, Tumour Necrosis Factor (TNF), and Others), By Route of Administration (Topical, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Geography.  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Plaque Psoriasis Treatment Market size was valued at USD 18.0 billion in 2021 It is growing at a significant CAGR of 10.0% from  2022–2028. As the prevalence of psoriasis rises worldwide, manufacturers are transforming breakthrough research into novel therapies by investing more in research. The number of medications approved for plaque psoriasis is constantly expanding, giving physicians and patients more treatment options. For instance, the FDA approved Eli Lilly's interleukin inhibitor, the second chemical after Novartis' Cosentyx. Companies are conducting various clinical trials and head-on-head trials with existing medications to create biologic therapies that will provide improved therapy alternatives for psoriasis patients. To encourage the acceptance of their breakthrough treatments, companies are increasingly offering co-pay choices to patients. According to the World Psoriasis Day consortium, psoriasis affects 125 million individuals worldwide. Novel systemic therapies using a variety of biologics are now being introduced. For instance, In April 2019, Ortho Dermatologics stated that an FDA-approved lotion for the treatment of psoriasis patients had been approved. The use of 'Duobrii' to treat plaque psoriasis has been authorized. Adults with plaque psoriasis will benefit from the product. In tandem with Duobrii to treat other significant psoriasis disorders, several efforts are being made to develop new products. The primary focus of the companies is on EU-5 and US countries to market the drugs. However, psoriasis incidence is higher in European countries like Netherlands, Norway, Denmark, and Austria and in Asia Pacific countries like China, Japan, and India. The expansion of the marketing of psoriasis drugs in these countries might provide an opportunity for the manufacturers to generate additional revenues. Celgene’s Otezla was launched in Germany, Switzerland, Austria, Scotland, and certain Scandinavian countries; the growth is expected from the expansion of the launch of OTEZLA in Europe and Japan markets, where it is well-positioned to repeat the success that is realized in the U.S. market. In October 2021, Sun Pharmaceutical Industries Ltd. announced the availability of ILUMYA in Canada to treat moderate-to-severe plaque psoriasis to strengthen its presence in Canada.

Plaque Psoriasis Treatment Market Summary

Study Period

2023-29

Base Year

2022

CAGR

10%

Largest Market

North-America

Fastest Growing Market

Europe
Plaque Psoriasis Treatment Market Dynamics Dynamics

The increasing prevalence of psoriasis conditions globally is projected to drive the sales of psoriasis drugs over the forecast period. Furthermore, an increase in awareness about the psoriasis conditions and active participation of non-profit organizations to bring awareness among psoriasis patients about the new therapies are expected to drive the plaque psoriasis market. On the other hand, the primary factor restraining the growth of the psoriasis market is the high cost of the drugs. Due to the drug’s higher price, the drugs are not affordable for all patients, and it has had a negative impact on the sales of the psoriasis drug market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Plaque Psoriasis Treatment Market Segmentation

By Product Type
  • Interleukin Inhibitors
    • Tildrakizumab
    • Guselkumab
    • Ixekizumab
    • Secukinumab
    • Ustekinumab
    • Brodalumab
  • Tumor Necrosis Factor (TNF)
    • Etanercept
    • Adalimumab
    • Infliximab
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
By Geography
  • North America
  • The U.S
  • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Rest of the world
    • Japan
    • China
    • India
    • Brazil
    • Others
LOCATION

Geography

Frequently Asked Questions

The plaque psoriasis treatment market is projected to expand at a CAGR of 10.0% during the forecast period.  

Novartis AG (Switzerland), AbbVie Inc.(U.S), Amgen, Inc. (U.S), Johnson & Johnson (U.S), Eli Lilly and Company (U.S)

North America is the fastest-growing region for plaque psoriasis treatment market

Plaque Psoriasis Treatment Market
  1. Executive Summary
  2. Global Plaque Psoriasis Treatment Market Introduction
2.1. Global Plaque Psoriasis  Treatment Market – Taxonomy
  1. Global Plaque Psoriasis Treatment Market Dynamics
3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Plaque Psoriasis  Treatment Market Dynamic Factors - Impact Analysis 3.6. Commercial Investments of Major Brands 3.7. Drug Development Programs of Major Brands
  1. Global Plaque Psoriasis Treatment Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023
4.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market Opportunity Analysis
  1. Global Plaque Psoriasis Treatment Market, By Product Type, 2015 - 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)
5.1. Interleukin Inhibitors 5.1.1. Tildrakizumab 5.1.1.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.1.3. Market Opportunity Analysis 5.1.2. Guselkumab 5.1.2.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.2.3. Market Opportunity Analysis 5.1.3. Ixekizumab 5.1.3.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.3.3. Market Opportunity Analysis 5.1.4. Secukinumab 5.1.4.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.4.3. Market Opportunity Analysis 5.1.5. Ustekinumab 5.1.5.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.5.3. Market Opportunity Analysis 5.1.6. Brodalumab 5.1.6.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.6.3. Market Opportunity Analysis 5.2. Tumor Necrosis Factor (TNF) Inhibitors 5.2.1. Etanercept 5.2.1.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.1.3. Market Opportunity Analysis 5.2.2. Adalimumab 5.2.2.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.2.3. Market Opportunity Analysis 5.2.3. Infliximab 5.2.3.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.3.3. Market Opportunity Analysis 5.3. Others 5.3.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.3.3. Market Opportunity Analysis
  1. Global Plaque Psoriasis Treatment Market Forecast, By Route of Administration, 2015 - 2017and Forecast, 2018 – 2023
6.1. Topical 6.1.1. Market Analysis, 2015 - 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Parenteral 6.2.1. Market Analysis, 2015 - 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 6.3. Others 6.3.1. Market Analysis, 2015 - 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.3.3. Market Opportunity Analysis
  1. Global Plaque Psoriasis Treatment Market Forecast, By Distribution Channel, 2015 - 2017and Forecast, 2018 – 2023
7.1. Hospital  Pharmacies 7.1.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. Retail Pharmacies 7.2.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Others 7.3.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis
  1. Global Plaque Psoriasis Treatment Market Forecast, By Region, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)
8.1. North America 8.1.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.1.3. Market Opportunity Analysis 8.2. Europe 8.2.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.2.3. Market Opportunity Analysis 8.3. RoW 8.3.1. Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.3.3. Market Opportunity Analysis 8.4. Global Plaque Psoriasis  Treatment Market - Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Region, 2018 – 2023
  1. North America Plaque Psoriasis Treatment Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)
9.1. Product Type Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.1.1. Interleukin Inhibitors 9.1.1.1. Tildrakizumab 9.1.1.2. Guselkumab 9.1.1.3. Ixekizumab 9.1.1.4. Secukinumab 9.1.1.5. Ustekinumab 9.1.1.6. Brodalumab 9.1.2. Tumor Necrosis Factor (TNF) Inhibitors 9.1.2.1. Etanercept 9.1.2.2. Adalimumab 9.1.2.3. Infliximab 9.1.3. Others 9.2. Route of Administration Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 9.2.1. Topical 9.2.2. Parenteral 9.2.3. Others 9.3. Distribution Channel Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 9.3.1. Hospital Pharmacies 9.3.2. Retail Pharmacies 9.3.3. Others 9.4. Country Analysis 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 9.4.1. U.S. 9.4.2. Canada 9.5. North America Plaque Psoriasis  Treatment Market - Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023
  1. Europe Plaque Psoriasis Treatment Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)
10.1. Product Type Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.1.1. Interleukin Inhibitors 10.1.1.1. Tildrakizumab 10.1.1.2. Guselkumab 10.1.1.3. Ixekizumab 10.1.1.4. Secukinumab 10.1.1.5. Ustekinumab 10.1.1.6. Brodalumab 10.1.2. Tumor Necrosis Factor (TNF) Inhibitors 10.1.2.1. Etanercept 10.1.2.2. Adalimumab 10.1.2.3. Infliximab 10.1.3. Others 10.2. Route of Administration Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.2.1. Topical 10.2.2. Parenteral 10.2.3. Others 10.3. Distribution Channel Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.3.1. Hospital Pharmacies 10.3.2. Retail Pharmacies 10.3.3. Others 10.4. Country Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.4.1. Germany 10.4.2. UK 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Rest of Europe 10.5. Europe Plaque Psoriasis  Treatment Market - Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023
  1. RoW Plaque Psoriasis Treatment Market Analysis, 2015 - 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)
11.1. Product Type Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.1.1. Interleukin Inhibitors 11.1.1.1. Tildrakizumab 11.1.1.2. Guselkumab 11.1.1.3. Ixekizumab 11.1.1.4. Secukinumab 11.1.1.5. Ustekinumab 11.1.2. Tumor Necrosis Factor (TNF) Inhibitors 11.1.2.1. Adalimumab 11.1.2.2. Infliximab 11.1.3. Others 11.2. Route of Administration Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.2.1. Topical 11.2.2. Parenteral 11.2.3. Others 11.3. Distribution Channel Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Others 11.4. Country Analysis 2015 - 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 11.4.1. Japan 11.4.2. China 11.4.3. India 11.4.4. Brazil 11.4.5. Others 11.5. Asia-Pacific Plaque Psoriasis  Treatment Market - Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023
  1. Competition Landscape
12.1. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis) 12.1.1. Novartis AG 12.1.2. AbbVie Inc. 12.1.3. Amgen, Inc 12.1.4. Johnson & Johnson 12.1.5. Eli Lilly and Company 12.1.6. Celgene Corporation 12.1.7. Sun Pharmaceuticals Industries Ltd.
  1. Research Methodology
  2. Key Assumptions and Acronyms
Figure 01: Global Plaque Psoriasis Treatment Market Revenue Share (%), by Product Type (2017) Figure 02: Global Plaque Psoriasis Treatment Market Revenue Share (%), by Route of Administration (2017) Figure 03: Global Plaque Psoriasis Treatment Market Revenue (US$ Mn), by Distribution Channel (2015, 2017, and 2023) Figure 04: Global Plaque Psoriasis Treatment Market Revenue Share (%) by Region (2017) Figure 05: Global Plaque Psoriasis Treatment Market - Regional Revenue Hotspots (2017) Figure 06: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2015-2023 Figure 07: Global Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2015, 2017, & 2023 Figure 08: Global Plaque Psoriasis Treatment Market Share (%), By Product Type 2018 & 2023 Figure 09: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Product Type, 2018 - 2023 Figure 10: Global  Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Interleukin Inhibitors 2015-2023 Figure 11: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Tumor Necrosis Factor (TNF) 2015-2023 Figure 12: Global  Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Others 2015-2023 Figure 13: Global Plaque Psoriasis Treatment Market Share (%), By Route of Administration 2018 & 2023 Figure 14: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Route of Administration , 2018 - 2023 Figure 15: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Topical administration, 2012-2023 Figure 16: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Parenteral administration, 2012-2023 Figure 17: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Others, 2012-2023 Figure 18: Global Plaque Psoriasis Treatment Market Share (%), By Distribution Channel, 2018 & 2023 Figure 19: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), By Distribution Channel, 2018 - 2023 Figure 20: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Hospital Pharmacies, 2012-2023 Figure 21: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Retail Pharmacies, 2012-2023 Figure 22: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn, By Others, 2012-2023 Figure 23: Global Plaque Psoriasis Treatment Market Share (%), By Region, 2018 & 2023 Figure 24: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Region, 2018 - 2023 Figure 25: North America Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023 Figure 26: Europe Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023 Figure 27: Rest of the world Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023 Figure 28: Global Plaque Psoriasis Treatment Market - Opportunity Analysis, By Product Type 2018 - 2023 Figure 29: Global Plaque Psoriasis Treatment Market - Opportunity Analysis, By Route of Administration, 2018 - 2023 Figure 30: Global Plaque Psoriasis Treatment Market - Opportunity Analysis, By Distribution Channel, 2018 - 2023 Figure 31: Global Plaque Psoriasis Treatment Market - Opportunity Analysis, By Country, 2018 - 2023 Figure 32: North America Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023 Figure 33: North America Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023 Figure 34: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017 Figure 35: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017 Figure 36: North America Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017 Figure 37: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017 Figure 38: North America Plaque Psoriasis Treatment Market - Opportunity Analysis, By Product Type 2018 - 2023 Figure 39: North America Plaque Psoriasis Treatment Market - Opportunity Analysis, By Route of Administration, 2018 - 2023 Figure 40: North America Plaque Psoriasis Treatment Market - Opportunity Analysis, By Distribution Channel, 2018 - 2023 Figure 41: North America Plaque Psoriasis Treatment Market - Opportunity Analysis, By Country, 2018 - 2023 Figure 42: Europe Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023 Figure 43: Europe Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023 Figure 44: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017 Figure 45: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017 Figure 46: Europe Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017 Figure 47: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017 Figure 48: Europe Plaque Psoriasis Treatment Market - Opportunity Analysis, By Product Type 2018 - 2023 Figure 49: Europe Plaque Psoriasis Treatment Market - Opportunity Analysis, By Route of Administration, 2018 - 2023 Figure 50: Europe Plaque Psoriasis Treatment Market - Opportunity Analysis, By Distribution Channel, 2018 - 2023 Figure 51: Europe Plaque Psoriasis Treatment Market - Opportunity Analysis, By Country, 2018 - 2023 Figure 52: RoW Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023 Figure 53: RoW Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023 Figure 54: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017 Figure 55: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017 Figure 56: RoW Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017 Figure 57: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017 Figure 58: RoW Plaque Psoriasis Treatment Market - Opportunity Analysis, By Product Type 2018 - 2023 Figure 59: RoW Plaque Psoriasis Treatment Market - Opportunity Analysis, By Route of Administration, 2018 - 2023 Figure 60: RoW Plaque Psoriasis Treatment Market - Opportunity Analysis, By Distribution Channel, 2018 - 2023 Figure 61: RoW Plaque Psoriasis Treatment Market - Opportunity Analysis, By Country, 2018 - 2023 Table 01: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023 Table 02: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023 Table 03: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023 Table 04: Global Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Region, 2012-2023 Table 05: North America Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023 Table 06: North America Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023 Table 07: North America Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023 Table 08: North America Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023 Table 09: Europe Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023 Table 10: Europe Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023 Table 11: Europe Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023 Table 12: Europe Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023 Table 13: RoW Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023 Table 14: RoW Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023 Table 15: RoW Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023 Table 16: RoW Plaque Psoriasis Treatment Market - Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023
  • Allergan
  • Johnson and Johnson
  • Amgen
  • Abbvie
  • Eli Lilly
  • Dermira Inc.
  • Novartis
  • Galectin Therapeutics
  • Cellceutix Corporation
  • Biogen Inc.
  • Bayer AG